Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children

May 11, 2023 updated by: Helena Moreira, University of Coimbra

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children: A Multicenter Study to Assess the Acceptability, Feasibility and Efficacy of a Blended Format of the Program in Portugal

The goal of this clinical trial is to test the efficacy of a blended format (i.e., a combination of face-to-face and online sessions into one integrated treatment protocol) of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in a sample of children aged between 7 and 12 years with a primary diagnosis of an anxiety disorder or with clinically significant levels of anxiety.

The main questions it aims to answer are:

  • Is the proposed intervention (named Emotion Detectives In-Out) feasible and acceptable among Portuguese children with anxiety disorders and their parents?
  • Is the Emotion Detectives In-Out intervention as effective as an evidence-based intervention for children's anxiety disorders in reducing anxiety symptomatology and changing secondary outcomes?
  • What are the key predictors of adherence to the Emotion Detectives In-Out intervention?
  • What are the key predictors of treatment outcomes?

Participants (children and one parent/legal representative) will:

  • Participate in an initial interview with a clinical psychologist, who will assess if children and parents meet eligibility criteria.
  • Complete an assessment protocol before, during, and after the intervention, as well as three months later.
  • Be randomly assigned to one of the two conditions: experimental (Emotion Detectives In-Out) or active control (Coping Cat).
  • Participate in one of the two psychological interventions. Researchers will compare the experimental and control groups to see if the Emotion Detectives In-Out intervention is equally efficacious as the Coping Cat intervention.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Childhood emotional disorders, particularly anxiety disorders, are an important public health concern due to their high and increasing prevalence, impact on children's functioning in multiple domains (e.g., family, academic, social), and long-term consequences. However, there is a significant gap between their needs and access to mental healthcare, with most children lacking access to evidence-based treatments (EBT). Several factors can contribute to a lack of adequate mental health care for children, including an insufficient number of trained clinicians, the difficulty of effectively disseminating the multitude of disorder-specific EBTs for emotional disorders to clinicians, and other barriers to face-to-face treatment. An Internet-based intervention can be an effective solution to overcome these difficulties. This project aims to develop and test the efficacy of a blended intervention of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C).

The UP-C is a cognitive-behavioral therapy (CBT) that takes a transdiagnostic approach to treating multiple emotional disorders simultaneously by addressing shared mechanisms underlying these disorders and employing a common set of EBT strategies (e.g., exposure, mindfulness). It is a child-friendly extension of the adult UP that delivers the UP core components in an interactive and child-friendly group format with extensive parent involvement. It has 15 weekly sessions for children and 15 weekly sessions for parents with an approximate duration of 90 minutes each. With a blended approach the researchers aim to improve the delivery of UP-C, by retaining the benefits of face-to-face and online therapy, while mitigating their limitations. This new version is expected to reduce costs of the therapy for families and institutions while also increasing compliance, motivation, uptake of treatment principles, and facilitating generalization of the application of core treatment components.

The blended version of the UP-C, named "Emotion Detectives In-Out" consists of 15 weekly sessions with the children (9 face-to-face group sessions, 4 online self-guided sessions and 2 videoconference sessions). The groups will consist of about 5 to 7 children. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists with specific training in the program. The online sessions were developed by the research team and are completely self-guided. These sessions last approximately 45 minutes. Parents will be asked to participate in 2 face-to-face sessions, 4 videoconference sessions and 10 self-guided online sessions.

Study Type

Interventional

Enrollment (Anticipated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Coimbra, Portugal, 3000-115
        • Faculty of Psychology and Educational Sciences
      • Lisbon, Portugal
        • Faculty of Psychology, University of Lisbon
        • Contact:
          • Ana Isabel Pereira, PhD
        • Principal Investigator:
          • Ana Isabel Pereira, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 12 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. The child is aged between 7 and 12 years;
  2. The child has a primary diagnosis of an anxiety disorder or clinically significant anxiety symptoms;
  3. Both the child and the parent are able to speak, read and understand Portuguese;
  4. Both the child and the parent have Internet access.

Exclusion Criteria:

  1. Diagnosis of a psychotic disorder, bipolar disorder, intellectual disability or autism spectrum disorder;
  2. Severe current suicidal ideation;
  3. The child is not on a stable dose of a psychotropic or other type of medication for at least 1 month prior to T0 assessment;
  4. The child has previously received CBT with exposure techniques.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Emotion Detectives In-Out
Emotion Detectives In-Out consists of 15 weekly sessions with the children (9 face-to-face group sessions, 4 online sessions and 2 videoconference sessions).
Emotion Detectives In-Out is a blended cognitive-behavioral intervention for children with emotional disorders aged between 7 to 12 years and their parents. It contains group sessions, online self-guided sessions and videoconference sessions. The groups will consist of about 5 to 7 children. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists with specific training in the program. The online sessions were developed by the research team and are completely self-guided. These sessions last approximately 45 minutes. Parents will be asked to participate in 2 face-to-face sessions, 4 videoconference sessions and 10 self-guided online sessions. It is a transdiagnostic and emotion-focused manualized cognitive-behavioral therapy designed to help children reduce the intensity and frequency of strong and aversive emotional experiences and to help parents reduce parental emotional behaviors.
Active Comparator: Coping Cat
Coping Cat consists of 16 weekly group sessions with the children (5 to 7 children per group) and 2 sessions with the parents.
Coping Cat is a cognitive behavioral therapy for children with anxiety aged between 7 to 13 years. Coping Cat consists of 16 weekly group sessions with the children (5 to 7 children per group) and 2 sessions with the parents. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale (RCADS).
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up]
The Revised Children's Anxiety and Depression Scale is a 47 item self-report questionnaire that measures symptoms of depression and anxiety in children and adolescents aged 8 - 18. It has 6 subscales: separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and low mood (major depressive disorder). It yields a Total Anxiety Scale (the sum of the 5 anxiety subscales) and a Total Anxiety & Depression Scale (sum of all 6 subscales). The Total Anxiety Scale ranges from 0 to 111, and the Total Anxiety & Depression scale ranges from 0 to 141, with higher scores indicating increased symptom severity.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up]
Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale - Parent version (RCADS-P).
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Revised Child Anxiety and Depression Scale - Parent Version (RCADS-P) is a 47 item parent-reported questionnaire that measures symptoms of depression and anxiety in children and adolescents aged 8 - 18. It has 6 subscales: separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and low mood (major depressive disorder). It yields a Total Anxiety Scale (the sum of the 5 anxiety subscales) and a Total Anxiety & Depression Scale (sum of all 6 subscales). The Total Anxiety Scale ranges from 0 to 111, and the Total Anxiety & Depression scale ranges from 0 to 141, with higher scores indicating increased symptom severity.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in anxiety symptoms as measured by the Clinician Global Impression - Improvement scale (CGC-I).
Time Frame: within 1 week post-treatment
Higher scores indicate increased symptom worsening.
within 1 week post-treatment
Change in severity of anxiety symptoms as measured by the Clinician Global Impression - Severity scale (CGC-S).
Time Frame: Baseline, within 1 week post-treatment
The Clinician Global Impression - Severity scale is a one-item measure assessing the clinician's perception of the severity of the patient's symptoms, with scores ranging from 1 (not at all ill) to 7 (extremely ill). Higher scores indicate increased symptom severity.
Baseline, within 1 week post-treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the interference of anxiety in child's life, as measured by the Child Anxiety Life Interference Scale - Self-Report (CALIS-C)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Child Anxiety Life Interference Scale - Self-Report consists of a 9-item scale administered to children. Items are rated on a 5-point Likert scale (0 = not at all to 4 = a great deal). The total score ranges from 0 to 36, with higher scores indicating greater interference of anxiety symptoms in children's life.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in the interference of anxiety in child's life, as measured by the Child Anxiety Life Interference Scale - Parent's Report (CALIS-P)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Child Anxiety Life Interference Scale - Parent's Report consists of two 9-item scales (Child Interference Subscale and Family Interference Subscale) administered to parents. Items are rated on a 5-point Likert scale (0 = not at all to 4 = a great deal). The total scores of the Child Interference Subscale and of the Family Interference Subscale range from 0 to 36, with higher scores indicating greater interference of anxiety symptoms in the lives of children and families, respectively.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's behavioral avoidance, as measured by the Child Avoidance Measure Self-Report (CAMS)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Child Avoidance Measure Self-Report is an 8-item self-report measure that assesses children's behavioral avoidance when faced with stimuli that elicit anxiety, fear, or worry, from the child's perspective. Items are rated on a 4-point Likert scale (0 = Almost Never to 3 = Almost Always). The total score ranges from 0 to 24, with higher scores indicating higher behavioral avoidance.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's behavioral avoidance, as measured by the Child Avoidance Measure Parent-Report (CAMP)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Child Avoidance Measure Parent-Report is an 8-item measure that assesses children's behavioral avoidance when faced with stimuli that elicit anxiety, fear, or worry, from the parents' perspective. Items are rated on a 4-point Likert scale (0 = Never, almost never, or not an issue to 3 = Almost Always). The total score ranges from 0 to 24, with higher scores indicating higher behavioral avoidance.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's positive and negative affect, as measured by the Positive and Negative Affect Schedule for Children - Short Version (PANAS-C-SF)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Positive and Negative Affect Schedule for Children - Short Version has 10 items and is composed by two subscales (Positive Affect and Negative Affect). Items are answered in a 5-item Likert scale that ranges from 1 (Very slightly or not at all) to 5 (Extremely). Both subscales can range from 5 to 25, with higher scores on Positive Affect indicating greater intensity of positive emotions, and higher scores on Negative Affect indicating greater intensity of negative emotions.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's anxiety sensitivity, as measured by the Children's Anxiety Sensitivity Inventory-Revised (CASI-R).
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Children's Anxiety Sensitivity Inventory-Revised is a 31 item self-report scale that measures children's anxiety sensitivity across four domains: fear of cardiovascular symptoms, fear of publicly observable anxiety reactions, fear of cognitive dyscontrol and fear of respiratory symptoms. Items are answered in a 3-item Likert scale that ranges from 0 (Not true) to 3 (Very true). A total anxiety sensitivity score can be obtained by summing across all items and ranges from 0 to 93, with higher scores indicating higher anxiety sensitivity.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's difficulties in emotion expression, as measured by the Emotional Expression Scale for Children (EESC)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Emotional Expression Scale for Children is a 16 item self-report questionnaire that assesses children's difficulties in emotion expression (i.e., poor emotion awareness and reluctance to express emotions). Items are answered on a 5-point Likert-type scale that ranges from 1 (Not at All True) to 5 (Extremely true). The total score ranges from 16 to 80, with higher scores indicating greater difficulty in expressing emotions.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's negative cognitive errors, as measured by the Children's Negative Cognitive Error Questionnaire (CNCEQ)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The Children's Negative Cognitive Error Questionnaire is a 24 item self-report questionnaire that assesses four types of cognitive errors: catastrophizing, overgeneralizing, personalizing, and selective abstraction. Items are answered on a 5-point scale that ranges from 1 (Nothing like I would think) to 5 (Exactly what I would think). A total cognitive distortion score can be obtained, ranging from 24 to 120. Higher scores indicate more distorted cognitive processes.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in children's quality of life, as measured by the KIDSCREEN-10 Index (Parent Report)
Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
The KIDSCREEN-10 Index (parent report) assesses children's overall levels of quality of life (physical, mental and social) as reported by their parents. Items are answered on a 5-point Likert scale ranging from 1 (never/not at all) to 5 (always/extremely). The sum of all items provides a global index of quality of life. The standardized scores ranges from 0 to 100, with higher results suggesting a better quality of life.
Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up
Change in parental overprotection, as measured by the Parental Anxiety and Overprotection Scale (PAOS)
Time Frame: Baseline, within 1 week post-treatment, 3 months follow-up
The Parental Anxiety and Overprotection Scale assesses parents' overprotection behaviors and other behaviors that aim to encourage children to cope with and face situations that cause them anxiety. The parental overprotection subscale has 7 items and the support of children's coping behaviors subscale has 3 items, which are both rated on a 5-point Likert scale ranging from 0 (nothing) to 4 (a lot). The total score of the overprotection subscale can range from 0 to 28 and total score of the support of children's coping behaviors subscale can range from 0 to 12, with higher scores indicating higher levels of parental overprotection and higher levels of parental supportive behaviors, respectively.
Baseline, within 1 week post-treatment, 3 months follow-up
Change in parental criticism as measured by the Egna Minnen Beträffande Uppfostran Scale (EMBU-P)
Time Frame: Baseline, within 1 week post-treatment, 3 months follow-up
The Rejection subscale of Egna Minnen Beträffande Uppfostran Scale assesses parents' levels of criticism towards their child. This subscale has 17 items answered on a 4-point Likert scale that ranges from 1 (No, never) to 4 (Yes, always). The total rejection score can range from 17 to 68, with higher scores suggesting higher levels of rejection and criticism.
Baseline, within 1 week post-treatment, 3 months follow-up
Change in parental modeling of intense emotions, as measured by the Parent Emotion Regulation Scale (PERS)
Time Frame: Baseline, within 1 week post-treatment, 3 months follow-up
The Parents' Lack of Emotional Control subscale of the Parent Emotion Regulation Scale assesses parents' lack of ability to modulate their own negative emotions in the presence of the child. This subscale has 4 items answered on a 5-point Likert scale that ranges from 0 (never or almost never) to 4 (always or almost always). The total score can range from 0 to 4, with higher scores indicating a higher level of negative emotion modeling.
Baseline, within 1 week post-treatment, 3 months follow-up
Change in parental inconsistency, as measured by the Parenting Inconsistency Scale
Time Frame: Baseline, within 1 week post-treatment, 3 months follow-up
Parenting Inconsistency Scale has 9 items answered on a 5-point Likert scale that ranges from 1 (does not describes me at all) to 5 (describes me completely). The total score can range from 1 to 5, with higher scores indicating a higher level of parental inconsistency.
Baseline, within 1 week post-treatment, 3 months follow-up
Change in parental depressive symptoms, as measured by the Patient Health Questionnaire-9 (PHQ-9).
Time Frame: Baseline, within 1 week post-treatment, 3 months follow-up
The Patient Health Questionnaire-9 is a brief self-report measure used to monitor the severity of depression symptoms. The scale has 9 items answered on a 4-point Likert scale that ranges from 0 (not at all) to 3 (nearly every day). The total score can range from 0 to 27, with higher scores indicating higher levels of depression severity.
Baseline, within 1 week post-treatment, 3 months follow-up
Change in parental anxiety symptoms, as measured by the General Anxiety Disorder-7 (GAD-7).
Time Frame: Baseline, within 1 week post-treatment, 3 months follow-up
The General Anxiety Disorder-7 is a brief self-report measure used to monitor the severity of anxiety symptoms. The scale has 7 items answered on a 4-point Likert scale that ranges from 0 (not at all) to 3 (nearly every day). The total score can range from 0 to 21, with higher scores indicating higher levels of anxiety severity.
Baseline, within 1 week post-treatment, 3 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parents' motivation to participate in the intervention, as measured by the Motivation for Change Rating Scale - Parental Version (MCRS)
Time Frame: Baseline
The Motivation for Change Rating Scale - Parental Version is a questionnaire developed by the research team for the purpose of assessing parents' motivation for change. The scale has 6 items answered on a 5-point Likert scale that ranges from 0 (nothing) to 4 (very much). The total score can range from 0 to 24, with higher scores indicating higher levels of motivation to change.
Baseline
Parents' self-efficacy and enjoyment in using the internet and technology
Time Frame: Baseline
Parents' self-efficacy and enjoyment in using technology will be measured by a questionnaire developed by the research team. The scale has 3 items answered on a 5-point Likert scale that ranges from 0 (nothing) to 4 (very much). The total score can range from 0 to 12, with higher scores indicating higher levels of self-efficacy and enjoyment.
Baseline
Children's self-efficacy and enjoyment in using the internet and technology
Time Frame: Baseline
Children's self-efficacy and enjoyment in using technology will be measured by a questionnaire developed by the research team. The scale has 3 items answered on a 5-point Likert scale that ranges from 0 (nothing) to 4 (very much). The total score can range from 0 to 12, with higher scores indicating higher levels of self-efficacy and enjoyment.
Baseline
Parental beliefs about child anxiety, as measured by the Parental Beliefs About Child Anxiety Questionnaire (PBA-Q)
Time Frame: Baseline
A brief version of the Parental Beliefs About Child Anxiety Questionnaire will be used to assess parents' anxious reactions to their children's physical symptoms and parents' negative beliefs about their children's experience of anxiety. The brief version has 4 items answered on a 4-point Likert scale that ranges from 0 (completely disagree) to 3 (completely agree). The total score can range from 0 to 12, with higher scores indicating higher levels of parents' negative beliefs about their children's experience of anxiety.
Baseline
Parents' involvement in therapy, as measured by the Parental Involvement in Therapy Scale (PITS)
Time Frame: within 1 week post-treatment
The Parental Involvement in Therapy Scale is a four-item scale that asks the clinician to evaluate parents' involvement in the therapy. Items are answered on a 5-point Likert scale that ranges from 0 to 5. The total score can range from 0 to 20, with higher scores indicating higher levels of parents' involvement.
within 1 week post-treatment
Feasibility of the intervention as measured by adherence
Time Frame: within 1 week post-treatment
The feasibility of the psychological interventions will be measured through adherence (number of treatment completers).
within 1 week post-treatment
Feasibility of the intervention as measured by drop-out rates
Time Frame: within 1 week post-treatment
The feasibility of the psychological interventions will be measured through dropout rates (number of participants that dropped out from the intervention before completing it).
within 1 week post-treatment
Feasibility of the intervention as measured by the pattern of the online sessions usage
Time Frame: within 1 week post-treatment
Measured through specific questions (to be developed by the researchers) to assess usability.
within 1 week post-treatment
Acceptability of the intervention
Time Frame: within 1 week post-treatment
Measured through specific questions (to be developed by the researchers) to assess acceptability.
within 1 week post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Helena Moreira, PhD, University of Coimbra

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2023

Primary Completion (Anticipated)

July 1, 2024

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

February 7, 2023

First Submitted That Met QC Criteria

February 16, 2023

First Posted (Actual)

February 28, 2023

Study Record Updates

Last Update Posted (Actual)

May 12, 2023

Last Update Submitted That Met QC Criteria

May 11, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PTDC/PSI-GER/0689/2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Disorders

Clinical Trials on Emotion Detectives In-Out

Subscribe